Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
5.11
+0.70 (15.87%)
At close: Mar 9, 2026, 4:00 PM EDT
5.10
-0.01 (-0.20%)
After-hours: Mar 9, 2026, 6:50 PM EDT
Rocket Pharmaceuticals Employees
Rocket Pharmaceuticals had 202 employees as of December 31, 2025. The number of employees decreased by 97 or -32.44% compared to the previous year.
Employees
202
Change (1Y)
-97
Growth (1Y)
-32.44%
Revenue / Employee
n/a
Profits / Employee
-$1,104,569
Market Cap
554.79M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Lyell Immunopharma | 300 |
| Entrada Therapeutics | 152 |
| Century Therapeutics | 150 |
| Kyverna Therapeutics | 129 |
| Lexeo Therapeutics | 61 |
| Altimmune | 59 |
| Zevra Therapeutics | 59 |
RCKT News
- 3 days ago - Rocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 11 days ago - Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress - Business Wire
- 14 days ago - Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire
- 7 weeks ago - Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program - Seeking Alpha
- 3 months ago - Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference - Business Wire
- 4 months ago - Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress - Business Wire